MedTrace Logo

Invasive Candidiasis in Critical Care

NCT06456151 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-06-05

No results posted yet for this study

Summary

The combination of acute phase marker monitoring and the "T2Candida" assay (name of the test) will represent an acceleration of the identification of the causative agent of mycotic infection, a significant improvement in the specificity and positive predictive value of this strategy in the diagnosis of invasive candidiasis and candidemia in ICU patients, thereby improving the clinical condition of patients and reducing the cost of specific antifungal therapy.

Conditions

  • Invasive Candidiasis

Interventions

DIAGNOSTIC_TEST

Invasive candidiasis test

The combination of acute phase marker monitoring and the T2Candida assay will be assessed.

OTHER

Urine sample collection for future research

Patients will be asked to provide a urine sample for future research (urine biobank).

Sponsors & Collaborators

  • University Hospital, Motol

    collaborator OTHER

  • University Hospital Ostrava

    lead OTHER

Principal Investigators

  • Hana Slepčanová, Mgr. · University Hospital Ostrava

Eligibility

Min Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-11
Primary Completion
2025-12-31
Completion
2027-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06456151 on ClinicalTrials.gov